您要查找的是不是：
- S100 immunoreactivity effectively rules out large B cell lymphoma. S100免疫反应可以有效地排除了大B细胞性淋巴瘤。
- "Distinct Types of Diffuse Large B Cell Lymphoma Identified by Gene Expression Profiling." Nature (2000). 藉由基因表现图谱判断不同类型的弥漫型大型B细胞淋巴瘤〉，《自然期刊》(2000).
- The diagnosis is diffuse large B cell lymphoma (also known as immunoblastic lymphoma). 主要需要鉴别的是转移癌。
- Objective: To evaluate the effectiveness and safety of rituximab combined with chemotherapy on diffused large B cell lymphoma (DLBCL) in clinic. 摘要目的：探讨利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤患者的临床疗效和安全性。
- ABSTRACT Purpose To investigate the characteristics of clinicopathology, immunohistochemistry and the DNA ploidy measurement for the primary large B cell lymphoma in mediastina. 摘要 目的：研究纵隔原发性大B细胞性淋巴瘤的临床病理、免疫组化及DNA倍体的表现。
- primary diffuse large B cell lymphoma of ovary 卵巢原发性弥漫性大B细胞淋巴瘤
- Intravaseular Large B Cell Lymphoma 血管内大B细胞淋巴瘤
- angiotropic large B cell lymphoma 嗜血管性大B细胞淋巴瘤
- intravascular large B cell lymphoma 血管内大B细胞淋巴瘤
- Construction of Heteroduplex DNA and in Vitro Model of Functional Analysis of Mismatch Repair as Well as Its Application in the Diffuse Large B Cell Lymphoma 异源双链DNA体外错配修复功能检测模型的构建及弥漫性大B细胞性淋巴瘤中错配修复系统的分析
- Keywords mismatch repair, functional analysis,heteroduplex DNA,microsatellite instability, PCNA, diffuse large B cell lymphoma （DLBCL）,occurrence mechanism; 错配修复;功能分析;异源双链DNA;微卫星不稳;PCNA;弥漫性大B细胞性淋巴瘤（DLBCL）;发病机制;
- diffuse large B cell lymphoma 弥漫性大B细胞淋巴瘤
- Case of B cell Lymphoma with First Sign as Infiltrated Plaque? 以皮肤浸润性斑块为首发表现的B细胞淋巴瘤1例?
- Fine-needle aspiration cytology from the pancreatic mass and endoscopic biopsy from duodenal tumor revealed lymphoma of diffuse large B cell origin. 超音波引导下以细针吸取胰脏肿瘤的细胞学检查及在内视镜下对此十二指肠肿块进行切片检查，均显示为大型B细胞型淋巴瘤。
- Keywords diffuse large B cell lymphomas;cytopathology;immunocytochemistry; 弥漫性大B细胞淋巴瘤;细胞病理学;免疫细胞化学;
- Objective To study the histopathologic features, prognosis and diagnostic significance of immunohistochemistry in T cell rich B cell lymphoma (TCRBCL). 目的探讨富于T细胞的大B细胞淋巴瘤的病理形态、预后和免疫组化的诊断意义。
- Histopathologic morphology presented as:centroblastic(CB,88.8%,87/98),immunoblastic(IB,5.1%,5/98),anaplastic(ALCL,3.1%,3/98),and T cell rich B cell lymphoma(TCRBCL,3.1%,3/98). 经病理形态学分型后;中心母细胞型占88.;7%25(87/98);免疫母细胞型占5
- diffuse large B cell lymphomas 弥漫性大B细胞淋巴瘤
- primary mediastinal B cell lymphoma PMBL
- Therefore, the antagonist of BAFF can be developed as drugs targeted to autoimmune diseases and B cell lymphomas. 因此，BAFF抑制剂的开发有望成为治疗某些自身免疫性疾病和一些B系淋巴瘤的新型药物。
